Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.
about
Abacavir/lamivudine combination in the treatment of HIV: a review.Abacavir and lamivudine for the treatment of human immunodeficiency virus.Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.
P2860
Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@en
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@nl
type
label
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@en
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@nl
prefLabel
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@en
Efficacy and safety of abacavi ...... antiretroviral-naive persons.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of abacavi ...... e antiretroviral-naive persons
@en
P2093
B Schmetter
CPRCA 058 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS
M Dehlinger
M van den Berg-Wolf
R D MacArthur
P2860
P304
P356
10.1310/WEQG-QTHL-DL3X-FTXC
P577
2004-11-01T00:00:00Z